Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug Candidates
Meenakshi Balganesh,Neela Dinesh,Sreevalli Sharma,Sanjana Kuruppath,Anju V. Nair,Umender Sharma +5 more
Reads0
Chats0
TLDR
It is shown that these four efflux pump KO mutants of M. tuberculosis play a vital role in mediating efflux of different chemical scaffolds and inhibitors of one or several of these efflux pumps could have a significant impact in the treatment of tuberculosis.Abstract:
Active efflux of drugs mediated by efflux pumps that confer drug resistance is one of the mechanisms developed by bacteria to counter the adverse effects of antibiotics and chemicals. To understand these efflux mechanisms in Mycobacterium tuberculosis, we generated knockout (KO) mutants of four efflux pumps of the pathogen belonging to different classes. We measured the MICs and kill values of two different compound classes on the wild type (WT) and the efflux pump (EP) KO mutants in the presence and absence of the efflux inhibitors verapamil and l-phenylalanyl-l-arginyl-β-naphthylamide (PAβN). Among the pumps studied, the efflux pumps belonging to the ABC (ATP-binding cassette) class, encoded by Rv1218c, and the SMR (small multidrug resistance) class, encoded by Rv3065, appear to play important roles in mediating the efflux of different chemical classes and antibiotics. Efflux pumps encoded by Rv0849 and Rv1258c also mediate the efflux of these compounds, but to a lesser extent. Increased killing is observed in WT M. tuberculosis cells by these compounds in the presence of either verapamil or PAβN. The efflux pump KO mutants were more susceptible to these compounds in the presence of efflux inhibitors. We have shown that these four efflux pumps of M. tuberculosis play a vital role in mediating efflux of different chemical scaffolds. Inhibitors of one or several of these efflux pumps could have a significant impact in the treatment of tuberculosis. The identification and characterization of Rv0849, a new efflux pump belonging to the MFS (major facilitator superfamily) class, are reported.read more
Citations
More filters
Journal ArticleDOI
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
TL;DR: By far the most widespread mechanism of resistance to AGs is the inactivation of these antibiotics by AG-modifying enzymes, and an overview of these mechanisms is provided.
Journal ArticleDOI
Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.
TL;DR: Mechanisms of phenotypic drug tolerance and resistance in bacteria are reviewed with the goal of providing a framework for understanding the similarities and differences in these cells.
Journal ArticleDOI
Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux
Richard E. Lee,Julian G. Hurdle,Jiuyu Liu,David F. Bruhn,Tanja Matt,Michael S. Scherman,Pavan K. Vaddady,Zhong Zheng,Jianjun Qi,Rashid Akbergenov,Sourav Das,Dora B. Madhura,Chetan Rathi,Ashit Trivedi,Cristina Villellas,Robin B. Lee,Rakesh,Samanthi L. Waidyarachchi,Dianqing Sun,Michael R. McNeil,José A. Aínsa,Helena I. Boshoff,Mercedes Gonzalez-Juarrero,Bernd Meibohm,Erik C. Böttger,Anne J. Lenaerts +25 more
TL;DR: The antitubercular efficacy of spectinamides demonstrates that synthetic modifications to classical antibiotics can overcome the challenge of intrinsic efflux pump-mediated resistance and expands opportunities for target-based tuberculosis drug discovery.
Journal ArticleDOI
Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital
Mei Deng,Man-Hua Zhu,Jun-Jie Li,Sheng Bi,Zi-Ke Sheng,Fei-Shu Hu,Jia-Jie Zhang,Wei Chen,Xiao-Wei Xue,Jifang Sheng,Lanjuan Li +10 more
TL;DR: This study showed that the active efflux pump AdeABC appeared to play important roles in the tigecycline resistance of A. baumannii, and phenyl-arginine-β-naphthylamide (PAβN) and carbonyl cyanide 3-chlorophenylhydrazone (CCCP) could partially reverse the resistance pattern of tigECYcline.
Journal ArticleDOI
Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation
Christina Kourtesi,Anthony R. Ball,Ying-Ying Huang,Sanjay M Jachak,D Mariano A Vera,Proma Khondkar,Simon Gibbons,Michael R. Hamblin,George P. Tegos +8 more
TL;DR: Advances in the path of EPI discovery are summarized, potential avenues of E PI implementation and development are discussed, and the need for highly informative and comprehensive translational approaches is underlined.
References
More filters
Journal ArticleDOI
The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis.
Edda De Rossi,Patrizio Arrigo,Marco Bellinzoni,Pedro E. A. Silva,Carlos Martin,José A. Aínsa,Paola Guglierame,Giovanna Riccardi +7 more
TL;DR: The inventory of the drug transporters subfamily, included in the major facilitator superfamily (MFS), encoded by the complete genome of Mycobacterium tuberculosis, revealed 16 open reading frames encoding putative drug efflux pumps belonging to MFS, and it is demonstrated that two of them function asDrug efflux proteins.
Journal ArticleDOI
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa
TL;DR: The structure activity relationship of these compounds showed other derivatives from PAβN that are higher in their activity with higher solubility in biological fluids and decreased toxicity level, which raises further questions on how can the authors compact Pseudomonas infections.
Journal ArticleDOI
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
TL;DR: It is shown that deletion of the Rv1410c gene encoding the P55 efflux pump made Mycobacterium tuberculosis strain more susceptible to a range of toxic compounds, including rifampin and clofazimine, which are first- and second-line antituberculosis drugs.
Journal ArticleDOI
Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump.
Noman Siddiqi,Ram Das,Niteen Pathak,Sharmistha Banerjee,Niyaz Ahmed,V. M. Katoch,Seyed E. Hasnain +6 more
TL;DR: A novel and definite association between drug resistance and transcription levels of a tap-like pump (Rv1258c) in a multi-drug resistant MTB patient isolate (ICC154) which possesses a unique genotypic signature.
Journal ArticleDOI
Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria
TL;DR: Data indicate that medicinal plant extracts may provide suitable lead compounds for future development and possible clinical utility as inhibitors of efflux for various Gram-negative bacteria.